ERNA Eterna Therapeutics Inc 748592 |
Income Statement |
Revenue
|
form10-q
|
487,000 |
Net Income
|
form10-q
|
-26,604,000 |
Profit Margin
|
|
-5462.83% |
Balance Sheet |
Current Assets
|
4,730,000 |
Assets
|
7,718,000 |
Current Liabilities
|
9,952,000 |
Liabilities
|
53,111,000 |
Equity
|
-45,393,000 |
Shares Out
|
5,411,000 |
Cash Flow Statement |
Operating Cash Flow
|
-12,291,000 |
Investing Cash Flow
|
-365,000 |
Market Analysis |
Market Cap
|
8,007,667 |
Price
|
0.42 |
BVPS
|
0.02 |
PB
|
29.14 |
EPS
|
-4.42 |
PS
|
4.11 |
FCF
|
-12,656,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ERNA documents filed with the SEC.
ERNA Filings
Clear